Abstract
An increasing evidence suggests that vanadium compounds are novel potential drugs in the treatment of diabetes, atherosclerosis, and cancer. Vanadium has also demonstrated activities against RNA viruses and is a promising candidate for treating acute respiratory diseases. The antidiabetic, antihypertensive, lipid-lowering, cardioprotective, antineoplastic, antiviral, and other potential effects of vanadium are summarized here. Given the beneficial antihyperglycemic and antiinflammatory effects as well as the potential mechanistic link between the COVID-19 and diabetes, vanadium compounds could be considered as a complement to the prescribed treatment of COVID-19. Thus, further clinical trials are warranted to confirm these favorable effects of vanadium treatment in COVID-19 patients, which appear not to be studied yet.
Keywords: COVID-19; Diabetes mellitus; Hyperglycemia; Inflammation; Insulin sensitivity; SARS-CoV-2 coronavirus; Vanadium.
【저자키워드】 COVID-19, Inflammation, Diabetes Mellitus, SARS-CoV-2 coronavirus, hyperglycemia, Insulin sensitivity, Vanadium, 【초록키워드】 Treatment, SARS-CoV-2, clinical trial, Antiviral, Cancer, Diabetes Mellitus, SARS-CoV-2 coronavirus, complement, drug, diabetes, respiratory diseases, activity, RNA viruses, Atherosclerosis, RNA virus, hyperglycemia, insulin, COVID-19 patients, Evidence, Antineoplastic, Insulin sensitivity, Lipid, Vanadium, Compound, activities, antihypertensive, Effect, antiinflammatory, antidiabetic, demonstrated, favorable effect, 【제목키워드】 therapeutic, Effect,